赛马鲁肽
医学
安慰剂
内科学
人口
临床终点
2型糖尿病
糖尿病
养生
随机对照试验
物理疗法
内分泌学
利拉鲁肽
替代医学
环境卫生
病理
作者
Weiqing Wang,Stephen C. Bain,Fang Bian,Rui Chen,Sanaz Gabery,Shan Huang,Thomas Bo Jensen,Bifen Luo,Guoyue Yuan,Guang Ning
标识
DOI:10.1007/s00125-024-06142-3
摘要
The aim of this study was to evaluate the efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes insufficiently controlled with diet and exercise alone.
科研通智能强力驱动
Strongly Powered by AbleSci AI